The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

Tim Berners-Lee, a British scientist, invented the World Wide Web (WWW) in 1989, while working at CERN. The Web was originally conceived and developed to meet the demand for automated ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

Explore the evolution and history of the Google logo design, from its humble beginnings as a simple wordmark to its iconic multi-coloured iteration. Google is one of the most widely used companies in ...

GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected earnings for Q4 ...

Banco Santander topped Stoxx 600 gains, up 8.3%, after the Spanish lender reported record quarterly profit. Pharma giant GSK closed 7.6% higher after hiking its long-term sales guidance and posting ...

British pharmaceutical giant GSK raised its long-term sales guidance on Wednesday as it posted a rise in full-year core operating profit and forecast sales growth of up to 5% in 2025. GSK's core ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant said Wednesday that the 2.0 billion ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential functional cure for the infectious disease. On a media call Wednesday morning ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares opened today ...